A woman who is at 12 weeks' gestation asks the nurse if she can ...

[acc299]

A woman who is at 12 weeks' gestation asks the nurse if she can undergo chorionic villus sampling (CVS) testing in order to determine whether her baby has a neural tube defect. Which response is best?
 
  1. No, because CVS testing is not performed until after 20 weeks' gestation.
  2. No, because CVS testing alone at any stage cannot detect neural tube defects.
  3. Yes, at 12 weeks' gestation, CVS can be used to diagnose a neural tube defect.
  4. Yes, at 12 weeks' gestation, CVS is combined with amniocentesis to diagnose neural tube defects.

Question 2

The nurse is reviewing nursing documentation related to the care of a client who had an amniocentesis. Which nursing note reflects appropriate client care?
 
  1. Prior to discharge, the client demonstrated vaginal spotting.
  2. An Rh-positive client received RhoGAM after the amniocentesis.
  3. The client was monitored for 30 minutes after completion of the test.
  4. The client reported that she takes insulin before each meal and at bedtime.

[kiamars2010]

Answer to Question 1

2
Explanation:
1. While CVS is typically performed between 10 and 13 weeks' gestation, this test cannot detect neural tube defects.
2. Because CVS testing is performed so early in the pregnancy, it cannot detect neural tube defects.
3. CVS is typically performed between 10 and 13 weeks' gestation; however, CVS does not detect neural tube defects.
4. CVS is typically performed between 10 and 13 weeks' gestation; however, amniocentesis is not performed until 15 weeks' gestation.

Answer to Question 2

3
Explanation:
1. Vaginal spotting after the amniocentesis is not an expected finding. A client experiencing vaginal bleeding of any amount after amniocentesis requires additional assessment and should not be sent home.
2. Only Rh-negative clients receive RhoGAM after amniocentesis. The Rh-positive client should not ever receive RhoGAM.
3. Twenty to 30 minutes of fetal monitoring is performed to assess for fetal well-being and to rule out injury of the fetus or placenta during the examination.
4. Whether or not a client takes insulin has nothing to do with amniocentesis. This answer does not relate to the question asked.

[acc299]

Thank you

[kiamars2010]

No problemo